PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D. Barish, Annette R. Atkins, Michael Downes et al. · Proceedings of the National Academy of Sciences · 2008
Lipid homeostasis and inflammation are key determinants in atherogenesis, exemplified by the requirement of lipid-laden, foam cell macrophages for atherosclerotic lesion formation. Although the nuclear receptor PPARdelta has been implicated in both systemic lipid metabolism and macrophage inflammation, its role as a therapeutic target in vascular disease is unclear. We show here that orally active PPARdelta agonists significantly reduce atherosclerosis in apoE(-/-) mice. Metabolic and gene expression studies reveal that PPARdelta attenuates lesion progression through its HDL-raising effect and anti-inflammatory activity within the vessel wall, where it suppresses chemoattractant signaling by down-regulation of chemokines. Activation of PPARdelta also induces the expression of regulator of G protein signaling (RGS) genes, which are implicated in blocking the signal transduction of chemokine receptors. Consistent with this, PPARdelta ligands repress monocyte transmigration and macrophage inflammatory responses elicited by atherogenic cytokines. These results reveal that PPARdelta antagonizes multiple proinflammatory pathways and suggest PPARdelta-selective drugs as candidate therapeutics for atherosclerosis.
Cited by 196 works. doi:10.1073/pnas.0711875105
Authors
- Grant D. Barish
- Annette R. Atkins
- Michael Downes
- Peter Olson
- Ling-Wa Chong
- Mike Nelson
- Hoosang Hwang
- Heonjoong Kang
- Linda K. Curtiss
- Ronald M. Evans
- Chih‐Hao Lee
References
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Inflammation and Atherosclerosis
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
- Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
- Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
- Atherosclerosis
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
- Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice